M. Ranjan et al. / Life Sciences 71 (2002) 115–126
125
[18] Labrie F, Sugimoto Y, Luee-The V, Simand J, Lachance Y, Bachvarov D, Leblanc G, Durocher F, Paquet N. Structure of
human type II 5-alpha-reductase gene. Endocrinology 1992;31(3):1571–3.
[19] Span PN, Bokhoven A, Smals AGH, Sweep CGJ, Schalken JA. Partial sequencing and tissue distribution of canine
isoforms of steroid 5-alpha-reductase type I and type II. Prostate 2000;44(3):233–43.
[20] Normington K, Russell DW. Tissue distribution and kinetic characteristics of rat steroid 5-alpha-reductase isozymes.
Evidence for distinct physiological functions. J Biol Chem 1992;267:19548–54.
[21] Wu L, Einnesein M, Geissler WM, Chan HK, Elliston KO, Andersson S. Expression cloning and characterization of
human 17-beta-hydroxysteroid dehydrogenase type 2, a microsomal enzyme possessing 20-alpha-hydroxysteroid dehy-
drogenase activities. J Biol Chem 1993;268:12964–9.
[22] Eichler W, Dreher M, Hoffmann R, Happle R, Aumuller G. Immunohistochemical evidence for differential distribution of
5-alpha-reductase isoenzymes in human skin. Brit J Dermatol 1995;133:371–6.
[23] Aumuller G, Eicheler W, Renneberg H, Aderman K, Vilja P, Forssman WG. Immunocytochemical evidence for
differential subcellular localization of 5-alpha-reductase isoenzymes in human tissues. Acta Anatomica 1996;156:
241–52.
[24] Luthe V, Sugimoto Y, Puy L, Labrie Y, Solache IL, Singh M, Labrie F. Characterization, expression, and immunohisto-
logical localization of 5-alpha-reductase in human skin. J Invest Dermatol 1994;102:221–6.
[25] Holt DA, Oh HJ, Levy MA, Metcalf BW. Synthesis of a steroidal A ring aromatic sulfonic acid as an inhibitor of steroid 5-
alpha-reductase. Steroids 1991;56:4–7.
[26] Peters DH, Sorkin EM. Finasteride: A review of its potential in the treatment of benign prostatic hyperplasia. Drugs
1993;46(1):177–208.
[27] Roberts JL, Fiedler V, Imperato-McGinley J, Whiting D, Olsen E, Shupack J, Stough D, DeVillez R, Rietschel R, Savin R,
Bergfeld W, Swinehart J, Funicella T, Hordinsky M, Lowe N, Katz I, Lucky A, Drake L, Price VH, Weiss D, Whitmore E,
Millikan L, Muller S, Gencheff C. Clinical dose ranging studies with finasteride, a type 2, 5-alpha-reductase inhibitor, in
men with male pattern hair loss. J American Acad Dermatol 1999;41(4):555–65.
[28] Levy MA, Brandt M, Kristina MS, Jeffrey TD, Dennis AH, Linda MG, Derk JB, Metcalf BW. Epristeride is a selective
and specific uncompetitive inhibitor of human steroid 5-alpha-reductase isoform 2. J Steroid Biochem Molec Biol
1994;48:197–206.
[29] Metcalf BW, Holt DA, Levy MA, Eeb JM, Heaslip JI, Brandt M, Oh HJ. Potent inhibition of human steroid 5-alpha-
reductase (EC 1.3.1.30) by 3-androsten-3-carboxylic acids. Bioorg Chem 1989;17:372–6.
[30] Sargent NSE, Habib FK. Partial purification of human prostatic 5 alpha-reductase (3-oxo-5a-steroid: NADP+ 4-oxido-
reductase) in a stable active form. J Steroid Biochem Molec Biol 1991;38:73–7.
[31] Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of
protein-dye binding. Anal Biochem 1976;72:248–54.
[32] Itami S, Kurata S, Takayasu S. 5-alpha-reductase activity in cultured human dermal papilla cells from beard compared with
reticular dermal fibroblasts. J Inves Dermatol 1990;94(1):150–2.
[33] Leshin M, Wilson J. Inhibition of steroid 5a-reductase from human skin fibroblasts by 17beta-N,N-diethylcarbamyl-4-
methyl-4-aza-5a-androstan-3-one. J Steroid Biochem 1982;17:245–50.
[34] Thigpen A, Russel D. Four-amino acid segments in steroid 5a-reductase confers sensitivity to finasteride, a competitive
inhibitor. J Biol Chem 1992;267:8577–83.
[35] Thigpen A, Cala K, Russel D. Characterization of Chinese hamster ovary cell lines expressing human steroid 5a-reductase
isozymes. J Biol Chem 1993;268:17404–12.
[36] Chen WC, Zouboulis CC, Blume-Peytavi U, Kodelja V, Luu-The V, Orfanos CE. Heterogeneity of skin type I 5a-
reductase. J Invest Dermatol 1988;110:84–9.
[37] Thiboutout DM, Knaggs H, Gilliland K, Hagaris S. Activity of type 1 5a-reductase is greater in the follicular infrain-
fundibulum compared with the epidermis. British J Dermatol 1997;136:166–71.
[38] Hudson RW. Comparison of nuclear 5-alpha-reductase activities in the stromal and epithelial fractions of human prostatic
tissue. J Steroid Biochem 1987;26:349–53.
[39] Bruchovsky N, Rennie PS, Batzold FH, Goldenberg SL, Fletcher T, McLoughlin MG. Kinetic parameters of 5a-reductase
activity in stroma and epithelium of normal, hyperplastic, and carcinomatous human prostates. J Clin Endocrionol Metab
1988;67(4):806–16.
[40] Negri-Cesi P, Colciago A, Poletti A, Motta M. 5-alpha-reductase isozymes and aromatase are differentially expressed and
active in the androgen-independent human cancer cell lines DU145 and PC3. Prostate 1999;41(4):224–32.